Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Article in Nature Communications (December 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Nature Communications (December 2023)
Article in Cytometry Part A (November 2018)
Article in Biosystems (March 2018)